Literature DB >> 33030588

Application of clockwise modularized laparoscopic lymphadenectomy in the suprapancreatic area, a propensity score matching study and comparison with open gastrectomy.

Hua Yang1, Wei-Han Zhang1, Kai Liu1, Yu-Qing Dan2, Xin-Zu Chen1, Kun Yang1, Zhi-Xin Chen1, Jia-Ping Chen1, Zong-Guang Zhou3, Jian-Kun Hu4.   

Abstract

BACKGROUND: Suprapancreatic lymphadenectomy is the essence of D2 radical gastric cancer surgery. The present study aimed to describe clockwise modularized laparoscopic lymphadenectomy in the suprapancreatic area.
METHODS: The data from gastric cancer patients who underwent surgical treatment from September 2016 to December 2018 were collected. Patients were divided into clockwise modularized lymphadenectomy (CML) and traditional open gastrectomy (OG) groups according to the surgical treatment strategy. The propensity score matching method was utilized to balance the baseline characteristics between the two groups.
RESULTS: Finally, 551 gastric cancer patients were included in the present study. Following propensity score matching, 106 pairs of patients in the CML group and OG group were included in the final analysis. The CML group had more total examined lymph nodes (36, IQR 28-44.74 vs. 29, IQR 29-39.5, p = 0.002) and no. 9 station nodes (2, IQR 1-5 vs. 2, IQR 1-3, p = 0.007) than the OG group. There was less intraoperative blood loss (30, IQR 20-80 ml vs. 80, IQR 50-80 ml, p < 0.001) and a longer surgical duration (262.5 min, IQR 220-303.25 min vs. 232, IQR 220-255 min, p < 0.001) in the CML group than in the OG group. The incidence of postoperative complications (19.8% vs. 16.0%, p = 0.591) and postoperative hospital stay (8, IQR 7-9 days vs. 8, IQR 7-9 days, p = 0.452) were comparable between the CML and OG groups.
CONCLUSION: Laparoscopic lymphadenectomy for gastric cancer surgery is technically demanding. Clockwise modularized laparoscopic lymphadenectomy in the suprapancreatic area can attain similar effects as traditional open surgery and without an increase in postoperative adverse events.

Entities:  

Keywords:  Gastric cancer; Laparoscopy; Lymphadenectomy; Pancreas

Mesh:

Year:  2020        PMID: 33030588      PMCID: PMC7886740          DOI: 10.1007/s00464-020-08070-w

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  28 in total

1.  Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial.

Authors:  Jiang Yu; Changming Huang; Yihong Sun; Xiangqian Su; Hui Cao; Jiankun Hu; Kuan Wang; Jian Suo; Kaixiong Tao; Xianli He; Hongbo Wei; Mingang Ying; Weiguo Hu; Xiaohui Du; Yanfeng Hu; Hao Liu; Chaohui Zheng; Ping Li; Jianwei Xie; Fenglin Liu; Ziyu Li; Gang Zhao; Kun Yang; Chunxiao Liu; Haojie Li; Pingyan Chen; Jiafu Ji; Guoxin Li
Journal:  JAMA       Date:  2019-05-28       Impact factor: 56.272

2.  Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.

Authors:  Yanfeng Hu; Changming Huang; Yihong Sun; Xiangqian Su; Hui Cao; Jiankun Hu; Yingwei Xue; Jian Suo; Kaixiong Tao; Xianli He; Hongbo Wei; Mingang Ying; Weiguo Hu; Xiaohui Du; Pingyan Chen; Hao Liu; Chaohui Zheng; Fenglin Liu; Jiang Yu; Ziyu Li; Gang Zhao; Xinzu Chen; Kuan Wang; Ping Li; Jiadi Xing; Guoxin Li
Journal:  J Clin Oncol       Date:  2016-02-22       Impact factor: 44.544

3.  A Multi-institutional, Prospective, Phase II Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901).

Authors:  Noriyuki Inaki; Tsuyoshi Etoh; Tetsuji Ohyama; Kazuhisa Uchiyama; Natsuya Katada; Keisuke Koeda; Kazuhiro Yoshida; Akinori Takagane; Kazuyuki Kojima; Shinichi Sakuramoto; Norio Shiraishi; Seigo Kitano
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

4.  Clockwise, Modularized Lymphadenectomy in Laparoscopic Gastric Cancer Surgery: a New Laparoscopic Surgery Model.

Authors:  Wei-Han Zhang; Kun Yang; Xin-Zu Chen; Ying Zhao; Kai Liu; Wei-Wei Wu; Zhi-Xin Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  J Gastrointest Surg       Date:  2018-10-23       Impact factor: 3.452

5.  Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT).

Authors:  Hyuk-Joon Lee; Woo Jin Hyung; Han-Kwang Yang; Sang Uk Han; Young-Kyu Park; Ji Yeong An; Wook Kim; Hyoung-Il Kim; Hyung-Ho Kim; Seung Wan Ryu; Hoon Hur; Seong-Ho Kong; Gyu Seok Cho; Jin-Jo Kim; Do Joong Park; Keun Won Ryu; Young Woo Kim; Jong Won Kim; Joo-Ho Lee; Min-Chan Kim
Journal:  Ann Surg       Date:  2019-12       Impact factor: 12.969

6.  Effect of Laparoscopic Distal Gastrectomy vs Open Distal Gastrectomy on Long-term Survival Among Patients With Stage I Gastric Cancer: The KLASS-01 Randomized Clinical Trial.

Authors:  Hyung-Ho Kim; Sang-Uk Han; Min-Chan Kim; Wook Kim; Hyuk-Joon Lee; Seung Wan Ryu; Gyu Seok Cho; Chan Young Kim; Han-Kwang Yang; Do Joong Park; Kyo Young Song; Sang-Il Lee; Seong Yeob Ryu; Joo-Ho Lee; Woo Jin Hyung
Journal:  JAMA Oncol       Date:  2019-04-01       Impact factor: 31.777

7.  Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry.

Authors:  Atsushi Nashimoto; Kohei Akazawa; Yoh Isobe; Isao Miyashiro; Hitoshi Katai; Yasuhiro Kodera; Shunichi Tsujitani; Yasuyuki Seto; Hiroshi Furukawa; Ichiro Oda; Hiroyuki Ono; Satoshi Tanabe; Michio Kaminishi
Journal:  Gastric Cancer       Date:  2012-06-23       Impact factor: 7.370

8.  Laparoscopic versus open gastrectomy for locally advanced gastric cancer: a systematic review and meta-analysis of randomized controlled studies.

Authors:  Katharina Beyer; Ann-Kathrin Baukloh; Carsten Kamphues; Hendrik Seeliger; Claus-Dieter Heidecke; Martin E Kreis; Maciej Patrzyk
Journal:  World J Surg Oncol       Date:  2019-04-15       Impact factor: 2.754

9.  Long-term Survival Outcomes of Laparoscopic Gastrectomy for Advanced Gastric Cancer: Five-year Results of a Phase II Prospective Clinical Trial.

Authors:  Sang-Hoon Ahn; So Hyun Kang; Yoontaek Lee; Sa-Hong Min; Young Suk Park; Do Joong Park; Hyung-Ho Kim
Journal:  J Gastric Cancer       Date:  2019-03-12       Impact factor: 3.720

10.  Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer.

Authors:  Yang Shu; Weihan Zhang; Qianqian Hou; Linyong Zhao; Shouyue Zhang; Jiankang Zhou; Xiaohai Song; Yan Zhang; Dan Jiang; Xinzu Chen; Peiqi Wang; Xuyang Xia; Fei Liao; Dandan Yin; Xiaolong Chen; Xueyan Zhou; Duyu Zhang; Senlin Yin; Kun Yang; Jianping Liu; Leilei Fu; Lan Zhang; Yuelan Wang; Junlong Zhang; Yunfei An; Hua Cheng; Bin Zheng; Hongye Sun; Yinglan Zhao; Yongsheng Wang; Dan Xie; Liang Ouyang; Ping Wang; Wei Zhang; Meng Qiu; Xianghui Fu; Lunzhi Dai; Gu He; Hanshuo Yang; Wei Cheng; Li Yang; Bo Liu; Weimin Li; Biao Dong; Zongguang Zhou; Yuquan Wei; Yong Peng; Heng Xu; Jiankun Hu
Journal:  Nat Commun       Date:  2018-06-30       Impact factor: 14.919

View more
  1 in total

1.  The Safety and Feasibility of Laparoscopic Gastrectomy after Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.

Authors:  Rui Ge; Kai Liu; Weihan Zhang; Kun Yang; Xiaolong Chen; Linyong Zhao; Zongguang Zhou; Jiankun Hu
Journal:  J Oncol       Date:  2022-05-31       Impact factor: 4.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.